Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1981 1
1983 1
1984 1
1985 3
1987 2
1988 2
1992 1
1993 2
1994 3
1995 5
1996 6
1997 3
1998 10
1999 6
2000 3
2001 8
2002 12
2003 8
2004 13
2005 13
2006 14
2007 11
2008 6
2009 8
2010 7
2011 15
2012 17
2013 9
2014 14
2015 6
2016 7
2017 4
2018 4
2019 9
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

231 results
Results by year
Filters applied: . Clear all
Page 1
Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy.
Goossens JF, Bailly C. Goossens JF, et al. Pharmacol Ther. 2019 Nov;203:107396. doi: 10.1016/j.pharmthera.2019.107396. Epub 2019 Jul 26. Pharmacol Ther. 2019. PMID: 31356908 Review.
Ursodeoxycholic acid (UDCA) is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism. ...The drug has rev …
Ursodeoxycholic acid (UDCA) is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid b …
Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).
Fan CQ, Crawford JM. Fan CQ, et al. J Clin Exp Hepatol. 2014 Dec;4(4):332-46. doi: 10.1016/j.jceh.2014.10.002. Epub 2014 Oct 30. J Clin Exp Hepatol. 2014. PMID: 25755580 Free PMC article. Review.
SOS, also known as veno-occlusive disease (VOD), occurs as a result of cytoreductive therapy prior to hematopoietic stem cell transplantation (HSCT), following oxaliplatin-containing adjuvant or neoadjuvant chemotherapy for colorectal carcinoma metastatic to the liv …
SOS, also known as veno-occlusive disease (VOD), occurs as a result of cytoreductive therapy prior to hematopoietic stem cell transplantatio …
Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults.
Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Weir TL, et al. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013. PLoS One. 2013. PMID: 23940645 Free PMC article.
Stool samples were collected from healthy adults (n = 10) and colorectal cancer patients (n = 11) prior to colon resection surgery at the University of Colorado Health-Poudre Valley Hospital in Fort Collins, CO. ...GC-MS profiling revealed higher concentratio …
Stool samples were collected from healthy adults (n = 10) and colorectal cancer patients (n = 11) prior to colon resect …
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Eaton JE, et al. Gastroenterology. 2013 Sep;145(3):521-36. doi: 10.1053/j.gastro.2013.06.052. Epub 2013 Jul 1. Gastroenterology. 2013. PMID: 23827861 Free PMC article. Review.
Ursodeoxycholic acid and chemoprevention of colorectal cancer.
Serfaty L, Bissonnette M, Poupon R. Serfaty L, et al. Gastroenterol Clin Biol. 2010 Oct;34(10):516-22. doi: 10.1016/j.gcb.2010.05.005. Epub 2010 Jul 6. Gastroenterol Clin Biol. 2010. PMID: 20609543 Free article. Review.
Colorectal cancer is respectively the third and second most common cancer among men and women in France. Interest in chemoprevention for colorectal cancer has increased over the last two decades. Beside non-steroidal anti-inflammatory drugs, …
Colorectal cancer is respectively the third and second most common cancer among men and women in France. Interest in ch …
Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development.
Pearson T, Caporaso JG, Yellowhair M, Bokulich NA, Padi M, Roe DJ, Wertheim BC, Linhart M, Martinez JA, Bilagody C, Hornstra H, Alberts DS, Lance P, Thompson PA. Pearson T, et al. Cancer Med. 2019 Feb;8(2):617-628. doi: 10.1002/cam4.1965. Epub 2019 Jan 16. Cancer Med. 2019. PMID: 30652422 Free PMC article. Clinical Trial.
It has been previously reported that ursodeoxycholic acid (UDCA), a therapeutic bile acid, reduced risk for advanced colorectal adenoma in men but not women. Interactions between the gut microbiome and fecal bile acid composition as a factor in …
It has been previously reported that ursodeoxycholic acid (UDCA), a therapeutic bile acid, reduced risk for advanced …
The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
Liu T, Song X, Khan S, Li Y, Guo Z, Li C, Wang S, Dong W, Liu W, Wang B, Cao H. Liu T, et al. Int J Cancer. 2020 Apr 1;146(7):1780-1790. doi: 10.1002/ijc.32563. Epub 2019 Jul 23. Int J Cancer. 2020. PMID: 31291465 Review.
The prevalence of colorectal cancer (CRC) has markedly increased worldwide in the last decade. Alterations of bile acid metabolism and gut microbiota have been reported to play vital roles in intestinal carcinogenesis. ...
The prevalence of colorectal cancer (CRC) has markedly increased worldwide in the last decade. Alterations of bile acid …
Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up.
Khoshpouri P, Habibabadi RR, Hazhirkarzar B, Ameli S, Ghadimi M, Ghasabeh MA, Menias CO, Kim A, Li Z, Kamel IR. Khoshpouri P, et al. Radiographics. 2019 Nov-Dec;39(7):1938-1964. doi: 10.1148/rg.2019180213. Epub 2019 Oct 18. Radiographics. 2019. PMID: 31626561 Review.
Patients are predisposed to various hepatic and extrahepatic deteriorating complications, such as bile duct and gallbladder calculi, acute bacterial cholangitis, liver abscess, and portal hypertension, as well as malignancies including cholangiocarcinoma (CCA), gallbladder can …
Patients are predisposed to various hepatic and extrahepatic deteriorating complications, such as bile duct and gallbladder calculi, acute b …
Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth.
Kim EK, Cho JH, Kim E, Kim YJ. Kim EK, et al. PLoS One. 2017 Jul 14;12(7):e0181183. doi: 10.1371/journal.pone.0181183. eCollection 2017. PLoS One. 2017. PMID: 28708871 Free PMC article.
INTRODUCTION: The regulation of reactive oxygen species (ROS) exists as a therapeutic target for cancer treatments. Previous studies have shown that ursodeoxycholic acid (UDCA) suppresses the proliferation of colon cancer cells. ...CONCLUSION: O …
INTRODUCTION: The regulation of reactive oxygen species (ROS) exists as a therapeutic target for cancer treatments. Previous studies …
Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer.
Centuori SM, Martinez JD. Centuori SM, et al. Dig Dis Sci. 2014 Oct;59(10):2367-80. doi: 10.1007/s10620-014-3190-7. Epub 2014 Jun 11. Dig Dis Sci. 2014. PMID: 25027205 Free PMC article. Review.
A high-fat diet coincides with increased levels of bile acids. This increase in bile acids, particularly deoxycholic acid (DCA), has been strongly associated with the development of colon cancer. Conversely, ursodeoxycholic acid (UDCA) may have …
A high-fat diet coincides with increased levels of bile acids. This increase in bile acids, particularly deoxycholic acid (DCA), has …
231 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page